Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.2%

4 terminated/withdrawn out of 18 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
8(44.4%)
N/A
6(33.3%)
Phase 2
2(11.1%)
Phase 3
1(5.6%)
Phase 4
1(5.6%)
18Total
Phase 1(8)
N/A(6)
Phase 2(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT03870776Phase 2Completed

RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode

Role: collaborator

NCT07050316Phase 1Completed

Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects

Role: collaborator

NCT03023540Phase 3Active Not Recruiting

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Role: collaborator

NCT03934229Not ApplicableCompleted

Effect of Study Probiotics on Body Fat Mass in Overweight and Obese Individuals Following Healthy Lifestyle Intervention

Role: collaborator

NCT02655393Phase 1Completed

A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects

Role: collaborator

NCT05154383Phase 4Completed

Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

Role: collaborator

NCT03740217Phase 1Completed

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

Role: collaborator

NCT03610334Phase 1Completed

A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088

Role: collaborator

NCT04792333Phase 1Completed

Pharmacokinetics in End Stage Renal Disease Patients

Role: collaborator

NCT04252417Phase 1Terminated

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Role: collaborator

NCT04252430Phase 1Terminated

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Role: collaborator

NCT03902340Not ApplicableUnknown

Comparison of the Efficacy, Tolerability and Safety of actiTENS to Those of Level 2 Analgesic Treatments.

Role: collaborator

NCT02882841Not ApplicableTerminated

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients

Role: collaborator

NCT02345096Not ApplicableTerminated

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Role: collaborator

NCT02534064Not ApplicableCompleted

Effect of Consumption of Yogurt Fortified in Calcium and Vit. D on Circulating Levels of 25OHD in Postmenopausal Women

Role: collaborator

NCT02189707Phase 2Completed

Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.

Role: collaborator

NCT02091310Phase 1Completed

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Role: collaborator

NCT02379312Not ApplicableCompleted

Comparison of the Satiety Effect of a Very Low Energy Foam With Normal Energy Foams

Role: collaborator

All 18 trials loaded